Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671069 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of MGL-3196 With Clopidogrel
A Phase 1 study, sponsored by Madrigal Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04671069 is a Phase 1 study that has completed, run by Madrigal Pharmaceuticals. The registered enrollment target is 20 participants.
The verdict
NCT04671069, a Phase 1 study, has completed, sponsored by Madrigal Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the single and multiple-dose pharmacokinetics (PK) of MGL-3196 are affected by co-administration with clopidogrel in healthy subjects.
Interventions
- DRUG Clopidogrel
- DRUG MGL-3196
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-26 |
| Est. Completion | 2019-09-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04671069
The ClinicalTrials.gov registry entry for NCT04671069 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Madrigal Pharmaceuticals, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clopidogrel is the first listed.
NCT04671069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04671069 about?
NCT04671069 is a clinical study titled "Drug Interaction Study of MGL-3196 With Clopidogrel". The purpose of this study is to determine whether the single and multiple-dose pharmacokinetics (PK) of MGL-3196 are affected by co-administration with clopidogrel in healthy subjects.
What is the current status of trial NCT04671069?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2019-07-26. Estimated completion is 2019-09-14.
What interventions are being tested in trial NCT04671069?
The interventions under investigation include: Clopidogrel (DRUG), MGL-3196 (DRUG).
Who is sponsoring clinical trial NCT04671069?
This trial is sponsored by Madrigal Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.